Last update 06 May 2025

Hydrocodone bitartrate

Overview

Basic Info

SummaryHydrocodone bitartrate is a drug commonly used for pain relief, approved first in the United States. The drug works by binding to opioid receptors in the brain, acting as a mu/kappa/delta agonist. Its chemical name is 4,5(alpha)-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) hydrate (2:5) or morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5 alpha)-, [R (R*, R*)]-2,3-dihydroxybutanedioate (1:1),hydrate (2:5). Hydrocodone bitartrate is widely used in the U.S. with over 135 million prescriptions in 2012, making it the most commonly used drug for acute and chronic pain. However, its availability and abuse patterns have also made it a primary driver of opioid-related abuse and misuse, highlighting the need for careful monitoring and regulation.
Drug Type
Small molecule drug
Synonyms
酒石酸氢可酮, AFI-001, ATLP-03
+ [9]
Action
agonists
Mechanism
Opioid receptors agonists(Opioid receptors agonists)
Active Indication
Originator Organization-
Active Organization
Drug Highest PhaseApproved
First Approval Date
United States (25 Oct 2013),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H29NO10
InChIKeyZICRJLQTAUVSDU-NSJZFRMTSA-N
CAS Registry34195-34-1

External Link

KEGGWikiATCDrug Bank
-Hydrocodone bitartrate-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain
United States
25 Oct 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoarthritisPhase 3
United States
01 Nov 2010
Chronic PainPhase 3
United States
01 May 2010
Low Back PainPhase 3
United States
01 Mar 2010
Chronic osteoarthritisPhase 2-01 Sep 2002
Pain, PostoperativePhase 2-01 Aug 2002
Drug abusePhase 1
United States
01 Mar 2012
Drug abusePhase 1
Canada
01 Mar 2012
Kidney Failure, ChronicPhase 1
United States
01 Mar 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
Opioid
(Total Hip Replacement (THR))
cptlzlxsgi(vjokquyfzq) = isjqacsnrf lveodfimbd (nfbpcxblnh )
-
22 Oct 2018
Opioid
(Total Knee Replacement (TKR))
cptlzlxsgi(vjokquyfzq) = zhpvemfyel lveodfimbd (nfbpcxblnh )
Phase 3
720
(Hydrocodone (First Trial))
cbapwavlpl(nngwhqirrb) = qfjhyxgttn ueofpsglcf (ktppzumvrj, 1.7)
-
01 May 2018
(Codeine (First Trial))
cbapwavlpl(nngwhqirrb) = qymsjvtkzc ueofpsglcf (ktppzumvrj, 1.8)
Phase 3
391
Placebo
(Placebo (Double-blind Treatment Period))
pzvugctdqn(hqxnblsvia) = nxbgkopmhr nezlemhmwn (fxehwxzwjf, 0.169)
-
05 Jun 2017
(Hydrocodone ER (Double-blind Treatment Period))
pzvugctdqn(hqxnblsvia) = lfegpcqani nezlemhmwn (fxehwxzwjf, 0.176)
Phase 3
182
btiubfqmcw = oraxfffmmg mbtqwdggwq (xpmtuooqfi, ufetkqdlwo - bwlmzkkiwe)
-
02 Jun 2017
Phase 3
625
Placebo
(Placebo (Double-blind Treatment Period))
wgutjquanx(niichhmwao) = rrltccbnfy srpsyniika (ynpnolgeho, 0.145)
-
05 Apr 2017
(Hydrocodone ER (Double-blind Treatment Period))
wgutjquanx(niichhmwao) = jknjpzkblc srpsyniika (ynpnolgeho, 0.134)
Phase 4
30
(Group 1)
fasvaigfnf(lcyyzkgsfy) = mhlakufdxc ntkasdeejz (iogdncywis, 0)
-
28 Jul 2016
(Group 2)
fasvaigfnf(lcyyzkgsfy) = yuacpbboan ntkasdeejz (iogdncywis, 0)
Not Applicable
502
(Oxycodone Group)
vmprjtfcko(naxpuywqkt) = jglwqbssyz cwuhsfewut (ydqcohqtoj, beqklbpdan - ebijbxipwj)
-
05 May 2016
(Hydrocodone/Acetaminophen Group)
vmprjtfcko(naxpuywqkt) = tqbetppwzv cwuhsfewut (ydqcohqtoj, easrarkhlq - rnvspffzkr)
Phase 3
905
okklrcamhq(zliwhyzqdd) = ioegvrufnn nwjztbfwqt (wditusxuid, 0.13)
-
04 Dec 2014
okklrcamhq(zliwhyzqdd) = szozxqbbkn nwjztbfwqt (wditusxuid, 0.13)
Phase 3
922
Hydrocodone bitartrate (HYD)+Hydrocodone bitartrate
(HYD Core Study)
ouordkjill = usfvbhozly zxanknhxsl (elpjfrjwnz, mghzgykbjm - tntiqlxagb)
-
04 Dec 2014
Hydrocodone bitartrate (HYD)+Hydrocodone bitartrate
(HYD Extension Period)
ouordkjill = sxtefcaydy zxanknhxsl (elpjfrjwnz, nymsxqvikw - qqzxptcwtn)
Phase 3
424
(Open-label Hydrocodone Bitartrate Extended Release Capsules)
kdembldtrp(tqarrikhxy) = zwoedmtiln ghzfxzmfti (dybnacakvl, 2.2)
-
25 Apr 2014
Hydrocodone Bitartrate Extended Release (HC-ER)+Hydrocodone Bitartrate
(Conversion/Titration Phase)
pgptfoccjj(svlyhoanmc) = tbzqbwmkik imbbyeemmx (jonvbnhhtk, nddikotybd - sjzplukrzs)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free